MRNA

• 1st lung cancer vaccine trials launch, powered by COVID mRNA technology

  The mRNA vaccine, known as BTN116, developed by the German biotechnology company BioNTech, is the first of its kind and has entered phase 1 clinical trials in seven countries.

  Health

  Aug 25
  
• Canadian study on COVID-19 heart health, vaccines gets funding boost

  A study by the Canadian Cardiovascular Society has received additional funding to investigate the impact of COVID-19 infections and COVID-19 mRNA vaccines on the heart.

  Canada

  Jun 22, 2023
  
• Advertisement
• Moderna suing Pfizer over patent for ‘foundational’ COVID-19 mRNA vaccine

  Moderna announced the lawsuits and alleged that the Pfizer/BioNTech vaccine 'infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology.'

  Canada

  Aug 26, 2022
• Advertisement
• B.C. scientist wins prestigious national award for work on mRNA COVID-19 vaccine

  Biochemist Pieter Cullis, former director of UBC's Life Sciences Institute, was named a winner of the 2022 Canada Gairdner International Award on Tuesday.

  Health

  Apr 8, 2022
• Moderna begins trial of HIV vaccine that uses mRNA technology

  Moderna credits mRNA technology for potentially shaving years off typical vaccine development times. First doses of the vaccine have been administered in a clinical trial.

  Health

  Jan 27, 2022
• Everest to bring Canada’s Providence Therapeutics’ COVID-19 vaccine to China

  Everest Medicines signed a licence agreement with Providence Therapeutics to make and sell the biotechnology company's potential mRNA COVID vaccines in some Asian countries.

  Health

  Sep 13, 2021
• Mississauga, Ont., plant tapped to make mRNA for Moderna’s COVID-19 vaccines

  While National Resilience Inc. will make mRNA for Moderna's COVID-19 vaccine, Moderna is still in the process of selecting a location for a vaccine manufacturing facility.

  Health

  Sep 9, 2021
• Atlantic provinces dispose of thousands of doses of expired AstraZeneca vaccine

  Canada secured 20 million doses of AstraZeneca through an advance purchase agreement, but demand for the vaccine has dropped as the supply of mRNA vaccines increased.

  Health

  Jul 15, 2021
• Advertisement
• ‘Premature’ to remove COVID restrictions with youth not yet eligible for vaccine: epidemiologist

  Studies are planned, or already underway, to determine how safe and effective the existing vaccines are for kids under the age 12.

  Health

  Jul 7, 2021
• Advertisement
• COVID-19 conspiracy theories deter some from getting vaccine

  False theories are sometimes responsible for people's hesitancy in getting the shot. Global News spoke to an expert about some of them.

  Canada

  Jul 5, 2021